InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (3 ops.)
Explore the detailed record of transactions filed by LeBel Carl, Directeur du Développement. Insider active across 1 companies, notably Frequency Therapeutics, Inc.. Aggregated, 4 reports have been logged. Total volume traded: €10k. The latest transaction was filed on 18 February 2022 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations4 total
€3,319974 shares@ €3.407433.9% of flow
Common Stock
SEC:0001127602-22-006321:0·
€3,241831 shares@ €3.899933.1% of flow
Common Stock
SEC:0001127602-22-005750:0·
€3,241831 shares@ €3.8999100.0% of flow
Common Stock
SEC:0001127602-22-005750·
15,000 shares
Common Stock
SEC:0001127602-22-005336:0·
4 of 4 declarations
About LeBel Carl
Carl LeBel serves as the Chief Development Officer at Frequency Therapeutics, Inc. He is responsible for leading the company's strategic development initiatives. With his expertise, he plays a key role in driving innovation and business growth.
